Dr. Eliot B. Friedman, MD

Dr. Friedman practices at Pulmonology Associates Inc in Wynnewood, Pennsylvania.

Dr. Friedman's NPI, 1659434165, was assigned on December 18, 2006. Dr. Friedman graduated from Central University of Venezuela in 1999. Dr. Friedman holds Pennsylvania license MD422904.

Dr. Friedman's primary practice is Pulmonology Associates Inc, at 100 Lancaster Ave, Wynnewood, PA 19096 in Montgomery County. The practice phone is (610) 642-3796.

Dr. Friedman's primary practice is Pulmonology Associates Inc in Wynnewood, Pennsylvania. Dr. Friedman is also affiliated with Lankenau Medical Center. The medical group on file is Pulmonology Associates. Dmand AI also links Dr. Friedman to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Friedman is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Friedman is licensed in Pennsylvania.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), hypersomnia, pleural effusion, pulmonary fibrosis, pulmonary heart disease and sleep apnea among the conditions Dr. Friedman treats.

CMS data shows 1,646 Medicare services from Dr. Friedman across 15 procedure codes in 2024, for 842 Medicare patients. Medicare paid $175,683 for them.

CMS counts 842 Medicare patients who saw Dr. Friedman in 2024. The largest group is 65 to 74, with 368 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 62, with 50% women.

In 2024, Dr. Friedman wrote 849 Medicare Part D claims for 176 patients. 57% of them were for generic drugs. CMS names the drug for 704 of them, across 28 drugs with 11 or more claims each, at $237,545 in total drug cost. In 2023, CMS named 433 claims across 18 drugs.

Dr. Friedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Friedman as offering telehealth.

Dmand AI links 4 papers to Dr. Friedman in 2015. The most frequent topics are Polysomnography. Dr. Friedman's most frequent co-authors are David Alan Asch, MD, Luqi Chi, MD and Sandeep Dhand, MD.

Dmand AI links Dr. Friedman to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis. Open Payments lists research payments to Dr. Friedman that name 1 trial.

CMS Open Payments shows 190 general payments to Dr. Friedman from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. GlaxoSmithKline, LLC. paid the most, $659. It also lists 1 research payment totaling $1,323 in 2023, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Friedman, most recently CMS Stage 1 EHR in 2013.

Dr. Friedman graduated from Central University of Venezuela in 1999.

Dr. Friedman is in network with 20 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.